ARCHIVES

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

This article is from The Cancer Letter archive.

Vol. 39 No. 18 | May 8, 2013

Download PDF Visit The Full Archive

Related Articles

Disease Oriented Programs Must Be Coordinated: Rabson

October 15, 1976

In Brief: Elizabeth Miller Dies; Mihich Names Associate Director At RPMI; AACR Calls For Abstracts

October 23, 1987

NCI Bypass Budget For FY 1992 Requests $2.6 Billion Support grows In Congress

May 18, 1990

What Is and Isn’t a Crime in Texas: CPRIT Official Indicted For Skipping Peer Review

December 13, 2013

ACS Defends Dialogue, Calls Story “Misleading”.

October 20, 2000

PRI Asks NIH To Cancel Recompetition Of Frederick Center Operations Contract

February 17, 1995